{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:27:27Z","timestamp":1777865247680,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["SBAG-117-S-041"],"award-info":[{"award-number":["SBAG-117-S-041"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["2018-ODL-ECZF-0018"],"award-info":[{"award-number":["2018-ODL-ECZF-0018"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejmech.2022.115049","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T19:53:10Z","timestamp":1671825190000},"page":"115049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Design, synthesis, in vitro \u2013 In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition"],"prefix":"10.1016","volume":"247","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0102-4181","authenticated-orcid":false,"given":"Huseyin","family":"Istanbullu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsah","family":"Bayraktar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsah","family":"Karakaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Akbaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nami Ege","family":"Perk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Cavus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crtomir","family":"Podlipnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kor","family":"Yereli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Ozbilgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilge","family":"Debelec Butuner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vildan","family":"Alptuzun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.115049_bib1","series-title":"Ending the Neglect to Attain the Sustainable Development Goals: A Road Map for Neglected Tropical Diseases 2021\u20132030","isbn-type":"print","year":"2020","ISBN":"https:\/\/id.crossref.org\/isbn\/9789240010352"},{"key":"10.1016\/j.ejmech.2022.115049_bib3","series-title":"Leishmaniasis, Resources for Health Professionals","year":"2022"},{"key":"10.1016\/j.ejmech.2022.115049_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/zph.12977","article-title":"The current epidemiology of leishmaniasis in Turkey, Azerbaijan and Georgia and implications for disease emergence in European countries","volume":"69","author":"Ozbel","year":"2022","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.ejmech.2022.115049_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/immuno2010015","article-title":"Host\u2013pathogen interaction in leishmaniasis: immune response and vaccination strategies","volume":"2","author":"Yasmin","year":"2022","journal-title":"Immuno"},{"key":"10.1016\/j.ejmech.2022.115049_bib6","series-title":"Control of the Leishmaniasis: Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases","isbn-type":"print","volume":"vol. 949","year":"2010","ISBN":"https:\/\/id.crossref.org\/isbn\/9789241209496"},{"key":"10.1016\/j.ejmech.2022.115049_bib7","series-title":"DNDi, Research & Development Portfolio","year":"2022"},{"key":"10.1016\/j.ejmech.2022.115049_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics3010001","article-title":"Utility of the biosynthetic folate pathway for targets in antimicrobial discovery","volume":"3","author":"Bourne","year":"2014","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2022.115049_bib9","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41375-021-01189-2","article-title":"Folate metabolism: a re-emerging therapeutic target in haematological cancers","volume":"35","author":"Zarou","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2022.115049_bib10","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.4155\/fmc-2018-0512","article-title":"Targeting pteridine reductase 1 and dihydrofolate reductase: the old is a new trend for leishmaniasis drug discovery","volume":"11","author":"das Neves","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115049_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1042\/bse0510063","article-title":"Folate metabolic pathways in Leishmania","volume":"51","author":"Vickers","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ejmech.2022.115049_bib12","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1016\/j.bbagen.2017.09.012","article-title":"Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors","volume":"1861","author":"Panecka-Hofman","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ejmech.2022.115049_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1057740","article-title":"Regulation of differentiation to the infective stage of the Protozoan parasite Leishmania major by tetrahydrobiopterin","volume":"292","author":"Cunningham","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.115049_bib14","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1080\/14756366.2019.1651311","article-title":"Dual and selective inhibitors of pteridine reductase 1 (PTR1) and dihydrofolate reductase-thymidylate synthase (DHFR-TS) from Leishmania chagasi","volume":"34","author":"Teixeira","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115049_bib15","doi-asserted-by":"crossref","first-page":"9218","DOI":"10.1073\/pnas.1820175116","article-title":"Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition","volume":"116","author":"Wyllie","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2022.115049_bib16","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.1021\/acs.jmedchem.0c00499","article-title":"Discovery and characterization of clinical candidate LXE408 as a kinetoplastid-selective proteasome inhibitor for the treatment of leishmaniases","volume":"63","author":"Nagle","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115049_bib17","series-title":"DNDi, Research & Development","author":"Drug for Neglected Diseases initiative","year":"2022"},{"key":"10.1016\/j.ejmech.2022.115049_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0166-6851(01)00213-4","article-title":"Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy","volume":"113","author":"Cunningham","year":"2001","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2022.115049_bib19","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1073\/pnas.0704384105","article-title":"Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development","volume":"105","author":"Cavazzuti","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2022.115049_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/expr.1997.4207","article-title":"Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways","volume":"87","author":"Hardy","year":"1997","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2022.115049_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/jm1010572","article-title":"Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase","volume":"54","author":"Ferrari","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115049_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900325","article-title":"Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds","volume":"353","author":"Istanbullu","year":"2020","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2022.115049_bib23","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1016\/j.ejmech.2009.09.012","article-title":"A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity","volume":"44","author":"Guglielmo","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115049_bib24","series-title":"[1,2,4]Triazolo[1,5-a]pyrimidine Derivatives as Protozoan Proteasome Inhibitors for the Treatment of Parasitic Diseases Such as Leishmaniasis","author":"Biggart","year":"2015"},{"key":"10.1016\/j.ejmech.2022.115049_bib25","series-title":"Compounds","author":"Brand","year":"2017"},{"key":"10.1016\/j.ejmech.2022.115049_bib26","first-page":"1","article-title":"Synthesis and in vitro antileishmanial efficacy of novel quinazolinone derivatives","author":"Prinsloo","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2022.115049_bib27","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.4314\/tjpr.v13i12.15","article-title":"Antileishmanial activity of selected Turkish medicinal plants","volume":"13","author":"Ozbilgin","year":"2014","journal-title":"Trop. J. Pharmaceut. Res."},{"key":"10.1016\/j.ejmech.2022.115049_bib28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11686-020-00285-0","article-title":"Overcoming the challenge; in vivo efficacy of miltefosine for chronic cutaneous leishmaniasis","volume":"66","author":"Tunal\u0131","year":"2021","journal-title":"Acta Parasitol."},{"key":"10.1016\/j.ejmech.2022.115049_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.actatropica.2017.05.032","article-title":"Leishmaniasis in Turkey: visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey","volume":"173","author":"Ozbilgin","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2022.115049_bib30","doi-asserted-by":"crossref","first-page":"8877","DOI":"10.1021\/acs.jmedchem.5b01412","article-title":"Noncovalent mutant selective epidermal growth factor receptor inhibitors: a lead optimization case study","volume":"58","author":"Heald","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115049_bib31","first-page":"10972","article-title":"Discovery of 6,7-dihydro-5H-pyrrolo[2,3-a]pyrimidines as orally available G protein-coupled receptor 119 Agonists","volume":"55","author":"Semple","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115049_bib32","series-title":"Purine Derivatives and Their Use as Pharmaceuticals for Prevention or Treatment of Bacterial Infections","author":"Atamanyuk","year":"2012"},{"key":"10.1016\/j.ejmech.2022.115049_bib33","series-title":"Quinazoline Compounds and Their Use in Therapy","author":"Brown","year":"2013"},{"key":"10.1016\/j.ejmech.2022.115049_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.exppara.2012.06.004","article-title":"Detection of anti-leishmanial effect of the Lucilia sericata larval secretions in vitro and in vivo on Leishmania tropica: first work","volume":"132","author":"Polat","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2022.115049_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5152\/tpd.2013.01","article-title":"Investigation of in vitro antileishmanial activity of moxifloxacin, linezolid and caspofungin on Leishmania tropica promastigotes","volume":"37","author":"Limoncu","year":"2013","journal-title":"Turk. Parazitoloji Derg."},{"key":"10.1016\/j.ejmech.2022.115049_bib36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.mimet.2003.08.013","article-title":"Hydrosoluble formazan XTT: its application to natural products drug discovery for Leishmania","volume":"55","author":"Williams","year":"2003","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.ejmech.2022.115049_bib37","doi-asserted-by":"crossref","first-page":"13883","DOI":"10.1074\/jbc.272.21.13883","article-title":"The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major","volume":"272","author":"Nare","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.115049_bib38","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, Accurate docking and scoring. 1. Method and assessment of docking Accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115049_bib39","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2022.115049_bib40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2022.115049_bib41","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision Glide: docking and scoring incorporating a model of hydrophobic enclosure for Protein\u2212Ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422009515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422009515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:03:23Z","timestamp":1777529003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422009515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":40,"alternative-id":["S0223523422009515"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115049","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, in vitro \u2013 In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115049"}}